Wealthspire Advisors (Maryland)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,479
Closed -$643K 523
2019
Q3
$643K Buy
6,479
+36
+0.6% +$3.42K 0.05% 216
2019
Q2
$596K Sell
6,443
-56
-0.9% -$5.32K 0.04% 228
2019
Q1
$613K Buy
6,499
+368
+6% +$32.2K 0.05% 218
2018
Q4
$393K Sell
6,131
-503
-8% -$37.1K 0.04% 266
2018
Q3
$594K Buy
6,634
+124
+2% +$11K 0.05% 209
2018
Q2
$517K Sell
6,510
-2,770
-30% -$230K 0.05% 232
2018
Q1
$828K Sell
9,280
-4,563
-33% -$438K 0.08% 154
2017
Q4
$1.45M Buy
13,843
+1,156
+9% +$130K 0.14% 103
2017
Q3
$1.85M Sell
12,687
-291
-2% -$39.6K 0.2% 81
2017
Q2
$1.69M Buy
12,978
+524
+4% +$64.2K 0.2% 81
2017
Q1
$1.55M Sell
12,454
-912
-7% -$109K 0.22% 66
2016
Q4
$1.55M Sell
13,366
-216
-2% -$24.1K 0.23% 67
2016
Q3
$1.42M Buy
13,582
+2,011
+17% +$218K 0.22% 70
2016
Q2
$1.14M Buy
11,571
+126
+1% +$13K 0.19% 86
2016
Q1
$1.15M Buy
11,445
+51
+0.4% +$5.25K 0.2% 79
2015
Q4
$1.36M Buy
+11,394
New +$1.32M 0.25% 67

Other funds holding CELG

Wealthspire Advisors (Maryland)'s CELG Position: Q4 2019 in Review

Wealthspire Advisors (Maryland) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,479 shares — an estimated $643K sold.

Wealthspire Advisors (Maryland) first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $1.85M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 6,479 Celgene Corp shares in Q4 2019, an estimated $643K.
  • Wealthspire Advisors (Maryland) first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Wealthspire Advisors (Maryland)'s Celgene Corp position peaked at $1.85M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q4 2019, filed 14 Feb 2020.